Immunization site pain: Case definition and guidelines for collection, analysis, and presentation of immunization safety data
Jane Gidudu(The Centers), Anne Schuind(GlaxoSmithKline (United States)), Harry Seifert(GlaxoSmithKline (United States)), James M. Oleske(Rutgers, The State University of New Jersey), Milivoj Jovančević(University of Zagreb), Scott A. Halperin(Dalhousie University), Neville A. Gibbs(United States Food and Drug Administration), William T. Zempsky(Connecticut Children's Medical Center), Anna Taddio(University of Toronto), Frederick Varricchio(Rutgers, The State University of New Jersey), Theodore F. Tsai(Novartis (Switzerland)), Eva Netterlid(Swedish Institute), Renald Hennig(Novartis (Germany)), Angela Calugar(Centers for Disease Control and Prevention), Terri O’Connor(Pennsylvania Department of Health), Gary A. Walco(Seattle Children's Hospital)
Cited by 34
Related Papers
Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS
|Science|1984|3.6k
Second symposium on the definition and management of anaphylaxis: Summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium
|Journal of Allergy and Clinical Immunology|2006|2.3k
Second Symposium on the Definition and Management of Anaphylaxis: Summary Report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network Symposium
|Annals of Emergency Medicine|2006|747
Understanding vaccine safety information from the Vaccine Adverse Event Reporting System
|The Pediatric Infectious Disease Journal|2004|381